EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NAD + , Axonal Maintenance, and Neurological Disease

Athanasios S Alexandris iD, Vassilis E Koliatsos

Antioxidants & Redox Signaling · 2023

DOI: 10.1089/ars.2023.0350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, 2023. Verfasst von Athanasios S Alexandris und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Neurodegenerative Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: The remarkable geometry of the axon exposes it to unique challenges for survival and maintenance. Axonal degeneration is a feature of peripheral neuropathies, glaucoma, and traumatic brain injury, and an early event in neurodegenerative diseases. Since the discovery of Wallerian degeneration (WD), a molecular program that hijacks nicotinamide adenine dinucleotide (NAD + ) metabolism for axonal self-destruction, the complex roles of NAD + in axonal viability and disease have become research priority. Recent Advances: The discoveries of the protective Wallerian degeneration slow (Wld S ) and of sterile alpha and TIR motif containing 1 (SARM1) activation as the main instructive signal for WD have shed new light on the regulatory role of NAD + in axonal degeneration in a growing number of neurological diseases. SARM1 has been characterized as a NAD + hydrolase and sensor of NAD + metabolism. The discovery of regulators of nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) proteostasis in axons, the allosteric regulation of SARM1 by NAD + and NMN, and the existence of clinically relevant windows of action of these signals has opened new opportunities for therapeutic interventions, including SARM1 inhibitors and modulators of NAD + metabolism. Critical Issues: Events upstream and downstream of SARM1 remain unclear. Furthermore, manipulating NAD + metabolism, an overdetermined process crucial in cell survival, for preventing the degeneration of the injured axon may be difficult and potentially toxic. Future Directions: There is a need for clarification of the distinct roles of NAD + metabolism in axonal maintenance as contrasted to WD. There is also a need to better understand the role of NAD + metabolism in axonal endangerment in neuropathies, diseases of the white matter, and the early stages of neurodegenerative diseases of the central nervous system. Antioxid. Redox Signal. 39, 1167–1184.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesNeurodegenerative DiseasesHumansWallerian DegenerationNADAxons

Stichwörter der Autor:innen

SARM1Wallerian degenerationaxonal degenerationneurodegenerationnicotinamidepellagra

Substanzen

NAD

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Athanasios S Alexandris

Förderung

  • NEI NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Alexandris, A. S., & Koliatsos, V. E. (2023). NAD + , Axonal Maintenance, and Neurological Disease. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0350

Vancouver

Alexandris AS, Koliatsos VE. NAD + , Axonal Maintenance, and Neurological Disease. Antioxidants & Redox Signaling. 2023. doi:10.1089/ars.2023.0350

BibTeX
@article{Alexandris2023,
  author = {Alexandris, Athanasios S and Koliatsos, Vassilis E},
  title = {NAD + , Axonal Maintenance, and Neurological Disease},
  journal = {Antioxidants & Redox Signaling},
  year = {2023},
  doi = {10.1089/ars.2023.0350}
}
Kostenlos starten →